Intrauterine exposure to drugs by mothers is not an uncommon finding ine our society. Due to the mother's suppression of a medical history, the diagnosis of neonatal abstinence syndrome is often missed. We report a case of a term, female, newborn, who presented with the following features;e restlessness, inconsolable crying, along with sweating, vigorous sucking; andadiarrhoea. No conclusion was derived from routine investigations. Eventually, with a high degree of suspicion regarding maternal drug addiction, her history was reviewed and it was discovered that the mother was a heroin addict. The baby was diagnosed as a case of Neonatal Abstinence Syndrome. The neonate was successfully managed thereafter and discharged.
INTRODUCTION
Neonatal Abstinence Syndrome(NAS) is a growing problem as the prevalence of drug abuse among women of the child-bearing age group is increasing over the years . 1 As a diagnosis, it is largely under-reported from South East Asia. This is due to the lack of disclosure of drug abuse, and also the symptoms are mostly non-specific, hence the diagnosis is often missed. A very high index of suspicion and focused history taking is required to identify such cases. We are reporting a case of NAS due to Heroin Withdrawal, which was timely diagnosed and successfully managed.
CASE REPORT
A full term female newborn weighing 2.2Kkg was born by Normal Vaginal delivery in a Tertiary Care Medical Centre, with an Apgar score of 7, 8 at first and fifth minute of birth respectively. TheMmother was a 28 year old, unbooked case, Para3 three with three living issues. Her HIV, VDRL and Hepatitis B status was tested after delivery and found to be negative. Parents were both street dwellers. The baby's birth weight was 2.25kg (<10th percentile), length 46cm (<10th percentile), and head circumference 33cm (< 25th percentile . The mother was malnourished and anaemic.
During initial questioning, no history was available regarding any form of addictio . At two hours of life, the baby developed fever and tachypnea and was admitted in the nursery. On admission, the patient's temperature was 38 0 c, respiratory rate 66/min, heart rate 142/min, capillary filling time less than3three seconds(not prolonged), blood pressure 66/46 (mean 53) mm of Hg. Subsequently, the baby also developed an abnormalrbehaviour pattern, consisting of excessive high-pitched crying, irritability, inconsolability, sweating andadiarrhoea. Baby had vigorous sucking and an exaggerated Moro's reflex. On the basis of these clinical features, a differential diagnosis of sepsis with meningitis, intracranialehaemorrhage,ahypocalcaemia,ah ypoglycaemia and thyrotoxicosis was entertained.
Investigations revealed a negative septic screen, CSF analysis, blood sugar and serum electrolytes were all within normal limits. Chest X-ray and ultrasound skull showed no abnormality and thyroid function test was also normal. This led to a diagnostic dilemma.
The history was reviewed again and it was discovered that the mother was a) heroin addict for the past5five years. She had been taking the drug by inhalation, during conception, and throughout pregnancy. Taking into account the history, clinical presentation and a normal laboratory profile, the patient was diagnosed as a case ofeNAS due to heroin withdrawal.
The patient was managed symptomatically and the Neonatal Abstinence Scoring System (NASS) 2 was meticulously followed. Within 24 hours of life of the baby, three consecutive NASS scores showed values greater than8eight and phenobarbitone was startedt 3mg/ Kg/day (Fig.1) . The maximum NASS score reached 12 on day3 three of life and the dose of phenobarbitone was increased to 8mg/Kg/day, after which, symptoms gradually decreased and phenobarbitone was gradually tapered off and discontinued by day 10 of life. TheBbaby was discharged afterg the mother was referred ton rehabilitation and counselling centrr.
DISCUSSION
The incidence of drug-exposed newborns has been reported to vary from 3% to 50%, depending on the specific patient population, with urbanscentres tending to report higher rates.
3 Amonge drug-exposed newborns, the incidence ofeNAS ranges from 60-87%, 4,5,6 though a study from the U.K. reported an incidence of 21 . The major drugs of abuse can be classified into four groups. They are-(I) Opiateesuch as morphine, methadone, and heroin; (II) CNS stimulantse such as amphetamines an cocaine; (III) CNS depressants like alcohol, barbiturates, benzodiazepines; (IV) and lastly Hallucinogens such as LSD. 3 The features of narcotic withdrawal have been summarized in Table 1 . 8 The onset of withdrawal symptoms vars from6 two to six hoursf with diazepam, to4 one to 144 hours withf heroin. 9 Similarly, the duration ofeNAS) is variable for different drugs. Neonates who do not exhibit symptoms of drug withdrawal within the first three days of life are unlikely to present with NAS requiring treatment. 6 Diagnosing NAS can bs made by screening tests in the meconium or urine of the newborn. Urine screening has a high false negative rate because only results for infants with recent exposure wille test as positive. Meconium drug testing, although not conclusive if results are negative, is more accurate than urine sampleo in identifying infants of drug -using mother. Meconium analysis was found toe have 96% sensitivite and 77% specificity. 10 The differential diagnosis includes central nervous system infections, metabolic disorders such asahypoglycaemia,ahypocalcaem ia, intracranialehaemorrhage and thyrotoxicosis. The aim of managing babies who suffer from NAS is to have a nonirritable baby without vomiting oradiarrhoea, who feeds well, sleeps well between feeds and is not heavily sedated. Currently it is stated that the administration of naloxone to an infant of a narcotic-addicted mother may result in abrupt drug withdrawal and seizures. 2 In the present case reported, the mother of the neonate was a heroin addict.
Heroin is an opioid and naloxone is a pure competitive opioid antagonist.Sso as a result, treatment with naloxone could precipitate immediate withdrawal symptoms and seizures. Management of such symptoms includse tight swaddlin; rocking, avoidance of excessive light and sound; fluid and electrolyte maintenance, monitoring of the newborn'se clinical condition by application of the(NAS) ; and lastly management of the social aspects . The NASS is based on vital parameters, sleeping patterns, the newborn's central nervous system, and the autonomic and gastrointestinal disturbances of thy newborn. TheMmost commonly used drugs for treatment of NAS is neonatal morphine solution (0.4mg/ml), a dose of which is titrated according to the newborn's NASS scores. 9 Other drugs are neonatal opium solution, paregoric, phenobarbitone, chlorpromazine, and diazepam. However, there is still little evidence regarding the efficacy of the different therapeutic regimes. It has been found that morphine treated newborns require a significantly shorter duration of treatment versus those treated with phenobarbitone. 5 Drugs of abuse that are contraindicated for use by mothers (who are already taking drugs) during breast-feeding include amphetamines, cocaine, heroin, marijuana, nicotine and phencyclidine . Drugs that should be used cautiously if a woman is breast-feeding include phenobarbital and benzodiazepines. Methadone is compatible with breast-feeding at a dose of less than 20mg every 24 hours. It has also been proven that drug exposure toe a nursing infant can be minimised if the mother takes medication just after completing nursing or just before an anticipated lengthy sleep period.
11
Case Report Figure 1 . A graphical representation of the relationship between dose of phenobarbitone and NASS scores These children are at risk of child abuse and neglect. Identification of these high-risk infants and appropriate intervention is critical. Organizations, which can specifically look into the needs of these compromised mothers and their children, are in desperate need in Nepal..
There is limited information regarding the prognosis and long-term consequences of perinatal addiction. It is also difficult to attribute neurological deficits to drug effects or to environmental conditions due to overlap . Several studies have identified increased neurological abnormalities such as articulation disorders, weak visual, motor and perceptual skills, and disruptive and aggressivelbehavioural problems. 
